Feng, C., Yu, A., Wang, Z., Wang, K., Chen, J., Wu, Y., . . . Huang, L. (2024). A novel PDPN antagonist peptide CY12-RP2 inhibits melanoma growth via Wnt/β-catenin and modulates the immune cells. Journal of Experimental & Clinical Cancer Research, 43(1), 1. https://doi.org/10.1186/s13046-023-02910-y
Chicago-referens (17:e uppl.)Feng, Chunyan, et al. "A Novel PDPN Antagonist Peptide CY12-RP2 Inhibits Melanoma Growth via Wnt/β-catenin and Modulates the Immune Cells." Journal of Experimental & Clinical Cancer Research 43, no. 1 (2024): 1. https://doi.org/10.1186/s13046-023-02910-y.
MLA-referens (9:e uppl.)Feng, Chunyan, et al. "A Novel PDPN Antagonist Peptide CY12-RP2 Inhibits Melanoma Growth via Wnt/β-catenin and Modulates the Immune Cells." Journal of Experimental & Clinical Cancer Research, vol. 43, no. 1, 2024, p. 1, https://doi.org/10.1186/s13046-023-02910-y.
